The White House sees an opening for a drug pricing deal with House Democrats before the end of President Donald Trump’s first term—provided impeachment doesn’t derail the entire process.
The White House Domestic Policy Council is working through technical aspects of a Medicare negotiation bill backed by House Speaker Nancy Pelosi (H.R. 3), Joe Grogan, director of the council and former Gilead Sciences lobbyist, said at Friends of Cancer Research and Prevision Policy’s Oct. 7 biopharma conference.
“The House deserves credit for getting into the fight,” he said. “It’s an ambitious bill, but we’re not quite ready ...